Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Stark, U; Brodmann, M; Lueger, A; Stark, G.
Antiarrhythmic effects of adenosine on ischemia-induced ventricular fibrillation.
J Crit Care. 2001; 16(1):8-16 Doi: 10.1053%2Fjcrc.2001.21791
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Brodmann Marianne
Lueger Andreas
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
PURPOSE: The antiarrhythmic efficacy of adenosine during states of AV-nodal reentrant tachycardias is well known and clinically established. Adenosine is also able to reduce ventricular arrhythmias when applied before coronary ligation in rats. Hypoxia or ischemia leads to an increased production of adenosine by cardiac myocytes.The purpose of this study was to evaluate if adenosine also has a direct antiarrhythmic effect on ischemia-induced ventricular fibrillation. MATERIALS AND METHODS: In this study, the antiarrhythmic effects of adenosine on ventricular fibrillation during global (low flow) ischemia were evaluated in isolated guinea pig hearts perfused by the method of Langendorff. RESULTS: Adenosine showed a dose-dependent prolongation of the peak to peak interval of the ventricular ECG signal during ventricular fibrillation until ventricular flutter or tachycardia occurred at a concentration of 2 mmol/L. At a concentration of 20 mmol/L, adenosine converted ventricular fibrillation into ventricular tachycardia with intermittent periods of asystole. This conversion of ventricular fibrillation to asystole was antagonised by 200 micromol/L theophylline. CONCLUSION: Adenosine appears to have an antiarrhythmogenic effect both in supraventricular and ventricular rhythm disturbances. During myocardial infarction, where huge amounts of adenosine are present in ischemic regions, asystole may respond to adenosine antagonists.
Find related publications in this database (using NLM MeSH Indexing)
Adenosine - analogs and derivatives
Animals - analogs and derivatives
Anti-Arrhythmia Agents - therapeutic use
Dipyridamole - pharmacology
Female - pharmacology
Guinea Pigs - pharmacology
Male - pharmacology
Myocardial Ischemia - complications
Receptors, Purinergic P1 - agonists
Theophylline - pharmacology
Ventricular Fibrillation - drug therapy

© Med Uni GrazImprint